Aditxt, Inc. is hosting a virtual fireside chat on October 28, 2024, featuring Saundra Pelletier, CEO of Evofem Biosciences, Inc. The event, moderated by Dr. Drew Pinsky, aims to provide an update on Aditxts recent acquisition of Evofem. The discussion will focus on postacquisition plans and how Aditxts support can enhance Evofems strategic vision. Pelletier…
Melodi Health, a medical device company based in Minneapolis, announced the successful closure of an oversubscribed $10.75 million Series A financing round. This funding milestone accompanies the launch of the ARIA investigational device exemption (IDE) trial, which aims to enhance clinical outcomes for women undergoing breast reconstruction postmastectomy. Melodi Health focuses on developing innovative medical…
Eximia Research has announced the integration of Tidewater Clinical Research into its national network of clinical trial sites. Tidewater, a leader in Womens Health and Ophthalmology research in the Hampton Roads/Eastern Virginia region, brings extensive expertise and a strong patient database to Eximias network. The acquisition will add Tidewaters 97,000 patients to Eximias nearly one…
Hologic, a global leader in women’s health, has completed its acquisition of Endomagnetics Ltd, a UKbased developer of breast cancer surgery technologies, for approximately $310 million. The acquisition adds Endomag’s wireless breast surgery localization and lymphatic tracing solutions to Hologic’s portfolio. Hologic President Erik Anderson is excited about the acquisition, noting the shared commitment to…
Novocuff, Inc., a medical device company dedicated to improving pregnancy outcomes and reducing the risk of preterm birth, has successfully closed an oversubscribed $26 million Series A funding round after raising an initial $2 million seed round. The funding will support Novocuffs growth plans, including the expansion of its team, execution of a U.S. multicenter…
Axena Health, a medical device company specializing in female pelvic health, has successfully closed a Series A funding round, raising an additional $9.4 million. The funding will be utilized to support the companys growth initiatives both in the United States and internationally. In the U.S., Axena Health will focus on the continued commercial launch of…